PTC Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
PTC Therapeutics, Inc. (PTCT) had Operating Leases, Future Minimum Payments, Due in Four Years of $712.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2018-03-06
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $712.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $177.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $176.00K.
- 2015-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.03M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2017-12-31 | $712.00K 10-K · filed 2018-03-06 |
| 2016-12-31 | $177.00K 10-K · filed 2017-03-16 |
| 2015-12-31 | $176.00K 10-K · filed 2016-02-29 |
| 2015-03-31 | $1.03M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $1.03M 10-K · filed 2015-03-02 |
| 2013-12-31 | $849.00K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |